WuXi Biologics Announces Positive Profit Alert

Monday, March 5, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

SHANGHAI, March 5, 2018 /PRNewswire/ -- WuXi Biologics (Stock Code: 2269.HK), a leading global

open-access biologics technology platform company that offers end-to-end solutions for biologics discovery, development and manufacturing, announced that based on the preliminary assessment of the unaudited consolidated management accounts of the Company
for the year ended December 31, 2017, the Company is expected to record an increase of approximately 75% to 80% in its net profit from RMB141 million for the year ended December 31, 2016 to an amount of approximately RMB247 million to RMB254 million for the year ended December 31, 2017.

During the Reporting Period, the Company incurred an unrealized foreign exchange loss due to a translation loss from the IPO proceeds (in U.S. Dollar) to Renminbi as a result of Renminbi appreciation against the U.S. Dollar. If the unrealized foreign exchange loss is excluded, the Company's net profit for the year ended December 31, 2017 is expected to be approximately RMB321 million to RMB328 million, representing a year-on-year growth of approximately 128% to 133%. Such an increase was primarily attributable to a strong growth in revenue driven by implementing the Company's "follow-the-molecule" strategy, and efficiency enhancement of the Company's business operation.

About WuXi Biologics

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and value proposition to our global clients. For more information on WuXi Biologics, please visit www.wuxibiologics.com.

Cision View original content:http://www.prnewswire.com/news-releases/wuxi-biologics-announces-positive-profit-alert-300607935.html

SOURCE WuXi Biologics



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store